Skip to main content

Published locations for CML-CP: Sustained long-term high treatment-free remission rates following frontline nilotinib

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CML-CP: Sustained long-term high treatment-free remission rates following frontline nilotinib

User login

  • Reset your password
  • /content/cml-cp-sustained-long-term-high-treatment-free-remission-rates-following-frontline-nilotinib
  • /hematology-oncology/article/238188/cml/cml-cp-sustained-long-term-high-treatment-free-remission